These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 8345609)

  • 1. Oral immunotherapy of recurrent urinary tract infections: a double-blind placebo-controlled multicenter study.
    Schulman CC; Corbusier A; Michiels H; Taenzer HJ
    J Urol; 1993 Sep; 150(3):917-21. PubMed ID: 8345609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunobiotherapy with Uro-Vaxom in recurrent urinary tract infection. The German Urinary Tract Infection Study Group.
    Tammen H
    Br J Urol; 1990 Jan; 65(1):6-9. PubMed ID: 2178724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of recurrent urinary tract infections: efficacy of an orally administered biological response modifier.
    Frey C; Obolensky W; Wyss H
    Urol Int; 1986; 41(6):444-6. PubMed ID: 3547993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Re: Oral immunotherapy of recurrent urinary tract infections: a double-blind placebo-controlled multicenter study.
    Pfau A
    J Urol; 1994 Jul; 152(1):173-4. PubMed ID: 8201659
    [No Abstract]   [Full Text] [Related]  

  • 5. Uro-Vaxom and the management of recurrent urinary tract infection in adults: a randomized multicenter double-blind trial.
    Magasi P; Pánovics J; Illés A; Nagy M
    Eur Urol; 1994; 26(2):137-40. PubMed ID: 7957468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral immunotherapy in paraplegic patients with chronic urinary tract infections: a double-blind, placebo-controlled trial.
    Hachen HJ
    J Urol; 1990 Apr; 143(4):759-62; discussion 762-3. PubMed ID: 2179584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of recurrent lower urinary tract infections by long-term administration of fosfomycin trometamol. Double blind, randomized, parallel group, placebo controlled study.
    Rudenko N; Dorofeyev A
    Arzneimittelforschung; 2005; 55(7):420-7. PubMed ID: 16080282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoactive prophylaxis of recurrent urinary tract infections: a meta-analysis.
    Naber KG; Cho YH; Matsumoto T; Schaeffer AJ
    Int J Antimicrob Agents; 2009 Feb; 33(2):111-9. PubMed ID: 18963856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of recurrent upper respiratory tract infections in a community of cloistered nuns using a new immunostimulating bacterial lysate. A randomized, double-blind clinical trial.
    Tricarico D; Varricchio A; D'Ambrosio S; Ascione E; Motta G
    Arzneimittelforschung; 2004; 54(1):57-63. PubMed ID: 14979610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of recurrent urinary tract infections with immuno-active E. coli fractions: a meta-analysis of five placebo-controlled double-blind studies.
    Bauer HW; Rahlfs VW; Lauener PA; Blessmann GS
    Int J Antimicrob Agents; 2002 Jun; 19(6):451-6. PubMed ID: 12135831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A long-term, multicenter, double-blind study of an Escherichia coli extract (OM-89) in female patients with recurrent urinary tract infections.
    Bauer HW; Alloussi S; Egger G; Blümlein HM; Cozma G; Schulman CC;
    Eur Urol; 2005 Apr; 47(4):542-8; discussion 548. PubMed ID: 15774256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Standardised high dose versus low dose cranberry Proanthocyanidin extracts for the prevention of recurrent urinary tract infection in healthy women [PACCANN]: a double blind randomised controlled trial protocol.
    Asma B; Vicky L; Stephanie D; Yves D; Amy H; Sylvie D
    BMC Urol; 2018 May; 18(1):29. PubMed ID: 29716563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaginal mucosal vaccine for recurrent urinary tract infections in women: results of a phase 2 clinical trial.
    Hopkins WJ; Elkahwaji J; Beierle LM; Leverson GE; Uehling DT
    J Urol; 2007 Apr; 177(4):1349-53; quiz 1591. PubMed ID: 17382730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections.
    Raz R; Stamm WE
    N Engl J Med; 1993 Sep; 329(11):753-6. PubMed ID: 8350884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low dose oestrogen prophylaxis for recurrent urinary tract infections in elderly women.
    Cardozo L; Benness C; Abbott D
    Br J Obstet Gynaecol; 1998 Apr; 105(4):403-7. PubMed ID: 9609266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of increasing leukocyturia for detecting the transition from asymptomatic bacteriuria to symptomatic infection in women with recurrent urinary tract infections: A new tool for improving antibiotic stewardship.
    Cai T; Lanzafame P; Caciagli P; Migno S; Mereu L; Mattevi D; Luciani LG; Tateo S; Malossini G; Bjerklund Johansen TE
    Int J Urol; 2018 Sep; 25(9):800-806. PubMed ID: 30008180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunostimulation with OM-85 in children with recurrent infections of the upper respiratory tract: a double-blind, placebo-controlled multicenter study.
    Schaad UB; Mütterlein R; Goffin H;
    Chest; 2002 Dec; 122(6):2042-9. PubMed ID: 12475845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Bacteriuria and Symptomatic Urinary Tract Infections during Antimicrobial Prophylaxis in Patients with Short-Term Urinary Catheters - Prospective Randomised Study in Patients after Joint Replacement Surgery].
    Dejmek M; Kučera T; Ryšková L; Čermáková E; Šponer P
    Acta Chir Orthop Traumatol Cech; 2017; 84(5):368-371. PubMed ID: 29351538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postcoital antimicrobial prophylaxis for recurrent urinary tract infection. A randomized, double-blind, placebo-controlled trial.
    Stapleton A; Latham RH; Johnson C; Stamm WE
    JAMA; 1990 Aug; 264(6):703-6. PubMed ID: 2197450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pilot study on prevention of catheter-related urinary tract infections with fluoroquinolones.
    Esposito S; Noviello S; Leone S; Marvaso A; Drago L; Marchetti F;
    J Chemother; 2006 Oct; 18(5):494-501. PubMed ID: 17127226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.